Recombinant DYRK1A was purified
as previously described60 (link) and was treated
with TEV protease to remove the N-terminal His6 tag. The
kinase at ∼13–15 mg/mL in 50 mM HEPES, pH 7.5, 500 mM
NaCl and 5 mM DTT was incubated with the inhibitors at 1 mM prior
to crystallization. Crystals were obtained using the sitting drop
vapor diffusion method at 4 °C using either 2 M ammonium sulfate,
0.2 M Na/K tartrate, 0.1 M citrate, pH 5.6 (for 5s and 5t), or 37% PEG 400, 0.2 M lithium sulfate, 0.1 M Tris, pH
8.8 (for 5j), as the reservoir solutions. Diffraction
data collected at Diamond Light Source, beamline I04-1, were processed
with XDS71 (link) or mosflm72 (link) and subsequently scaled with Scala from CCP4 suite.73 (link) Structures were determined by molecular replacement
method using Phaser74 (link) and the coordinates
of DYRK1A structure60 (link) as a search model.
Iterative cycles of manual model building in COOT75 (link) alternated with refinement using Refmac,76 (link) and a TLS model calculated from TLSMD server77 (link) was performed. The geometric correctness of
the final model was verified with MolProbity.78 (link) Data collection and refinement statistics are summarized in Table 3. DYRK1A-ligand complexes (pdb id): DYRK1A-5j (4YLJ); DYRK1A-5s (4YLK); DYRK1A-5t (4YLL).